Reserch Core Unit Next Generation Sequencing

As of January 01, 2017, the Research Core Units Transcriptomics and Next Generation Sequencing have been merged and ,thereby, became the new Research Core Unit Genomics.

Please visit our new homepage exclusively for current requests.

Below you will find some selected information of the former home page with a short description of the basic conception at that time.

The Research Core Unit Next Generation Sequencing (RCU-NGS), newly founded in 2015, pursues the goal of providing access to NGS technology for all clinics and institutes conducting research at MHH.

The starting point of this initiative was a meeting on October 23, 2014, attended by our university president. At this meeting, a first basic concept was presented and discussed in detail (see minutes (German only)).

In the meantime, a 5-member steering committee has been firmly constituted, which has developed a plan for the next 2 years with regard to further expansion, as well as a longer-term concept (2015-2018) (German only). The overall concept has been submitted to the Executive Board for final review.

The Steering Committee has set the following overall goals:

  1. Pooling and efficient utilization of the expertise and NGS instrument infrastructure available at MHH to date.
  2. Supervision of NGS project requests (experimental design, experimental implementation, cost processing, data evaluation, application).
  3. Acquisition and operation of a powerful sequencer from Illumina.
  4. Gradual further expansion (German only) of the institution towards a high-performance, nationally and internationally competitive core unit "Nucleic Acid Analysis and Bioinformatics".

At the moment, the entire personnel input of the Core Unit is fed by the commitment that the members of the Steering Committee or their staff can bring to the RCU-NGS in addition to their other core tasks.


However, this fact should not discourage you from approaching us with your specific NGS project plans. In fact, a high demand for NGS projects helps us to give our overall concept the necessary additional emphasis.

Do you have a concrete NGS project proposal? Then we would be pleased if you contact us via our inquiry form.

Steering Group:
Genomics: Dr. Lutz Wiehlmann
Epigenomics: Prof. Dr. Helge Frieling
Transcriptomics: Dr. Oliver Dittrich-Breiholz (Sprecher)
Pathogenomics: Prof. Dr. Sebastian Suerbaum
Clinical Specimens: Prof. Dr. Thomas Illig